SAVANNAH SNELL: Open Payments
NPI 1639809486 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 14 payments from 10 companies in 2025. Trend: 2023 $35 · 2024 $247 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $43 |
| Novo Nordisk Inc | 2 | $37 |
| Dexcom, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $30 |
| KYOWA KIRIN, INC. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $13 |
Products named: MOUNJARO, CRYSVITA, Ozempic, JOURNAVX, Dexcom G6 Transmitter, DEXCOM G7 GSS (161), Veozah, SHINGRIX.
Industry payments across KS — which companies pay providers there.
